RepliCel Life Sciences
RepliCel Life Sciences engages in developing hair follicle cell replication technology for patients suffering from androgenetic alopecia. Learn more
Launch date
Employees
Market cap
CAD3.6m
Enterprise valuation
CAD4m (Public information from Jul 2024)
Share price
CAD0.055 RP.V
North Vancouver British Columbia (HQ)
Authorizing premium user...